| Sleep Disorders |
1 |
1 |
| Hypersomnia |
0 |
1 |
| Sleep |
0 |
0.48 |
| Food and Drug Administration (FDA) |
0 |
0.6 |
| Cognitive Impairment |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.09 |
| Xerostomia |
0 |
0.09 |
| Anxiety Disorder |
0 |
0.07 |
| Dentistry and Oral Health |
0 |
0.07 |
| Dermatitis |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Headache |
0 |
0.07 |
| Hyperhidrosis |
0 |
0.07 |
| Mild Cognitive Impairment |
0 |
0.07 |
| Osteoarthritis |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Abuse |
0 |
0.06 |
| Anxiety |
0 |
0.06 |
| Calcium |
0 |
0.06 |
| Cataplexy |
0 |
0.06 |
| Central Nervous System |
0 |
0.06 |
| Dizziness |
0 |
0.06 |
| Emesis |
0 |
0.06 |
| Fatigue |
0 |
0.06 |
| Health Care Quality, Access, and Evaluation |
0 |
0.06 |
| Id Reaction |
0 |
0.06 |
| Impairment |
0 |
0.06 |
| Insomnia |
0 |
0.06 |
| Mouth |
0 |
0.06 |
| Narcolepsy |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| Tremor |
0 |
0.06 |